Management Excellence Recognized: National Institute for Korean Medicine Development Earns A Grade for 4 Consecutive Years in Performance Evaluation

ESG Value System Incorporated Across All Areas of Management
Highest Overall Scores in Quantitative and Non-Quantitative Indicators for Two Consecutive Years

The National Institute for Korean Medicine Development has been selected as an excellent institution with an A grade for the fourth consecutive year in the '2024 Other Public Institutions Management Performance Evaluation' organized by the Ministry of Health and Welfare.

National Institute for Korean Medicine Development

The 2024 management performance evaluation was conducted for a total of 24 institutions: the existing 18 institutions under the Ministry of Health and Welfare, five institutions whose classification changed from quasi-governmental organizations to other public institutions, and one newly added institution.

The National Institute for Korean Medicine Development achieved the highest score for two consecutive years in both quantitative and non-quantitative indicators. The institute also received positive evaluations for incorporating ESG value systems across all areas of management and for its collaborative efforts to enhance ESG capabilities among partner companies and related organizations.

Additionally, the institute received high marks for its operation of communication channels that include industrial sites, public opinion collection, and diverse social groups, as well as for establishing a digital-based real-time communication system. In its main business areas, such as expanding the foundation for the overseas advancement of the Korean medicine industry and implementing innovation plans for public institutions, the institute was also highly evaluated.

Shin Jesu, Acting President of the National Institute for Korean Medicine Development, stated, "Receiving an A grade for four consecutive years in the management performance evaluation is the result of the efforts of our members, as well as the strong support from the public for the scientific advancement and standardization of Korean medicine. As a leading institution for the promotion of the Korean medicine industry, we will further strengthen our ESG management system and create new future value for Korean medicine."